Is a complete BCBA/PFE research report available?

No complete published report is available for bcba/PFE (BCBA/PFE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bcba/PFE stock profile: metrics, valuation and analysis

Market cap	238.4T
Revenue (ttm)	93.9T
Net income (ttm)	6.4T
EPS (ttm)	ARS 1,120
P/E (trailing)	37.3x
P/E (forward)	9.6x
Dividend	ARS 390 (3.52%)
Volume	7,983
Beta	0.28

All BCBA/PFE indicators

Market & fundamental data

Available fields

242

Groups with data

Currency

USD

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	75,000
Employees Change	-7,000%
Employees Change Percent	-7.95
Enterprise value	ARS 317.1T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	ARDEUT111424
Last refreshed	2026-09-12
Market cap	ARS 238.4T
Price	ARS 11,100
Price currency	ARS
Rev Per Employee	1,252,008,576x
Sector	Healthcare
Sic	2834
Symbol	bcba/PFE
Website	https://www.pfizer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.68%
EV Earnings	49.64x
EV/EBIT	11.13x
EV/EBITDA	7.97x
EV/FCF	19.58x
EV/Sales	3.29x
FCF yield	6.79%
Forward P/E	9.63x
P/B ratio	1.89x
P/E ratio	37.31x
P/S ratio	2.54x
PE Ratio10 Y	18.97x
PE Ratio3 Y	26.74x
PE Ratio5 Y	19.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	29.58%
EBITDA Margin	39.85%
FCF margin	16.81%
Gross margin	74.72%
Gross Profit	ARS 70.2T
Gross Profit Growth	2.68%
Gross Profit Growth Q	2.04%
Gross Profit Growth3 Y	-4.76%
Gross Profit Growth5 Y	3.85%
Net Income	ARS 6.4T
Net Income Growth	-59.69%
Net Income Growth Years	0%
Net Income Growth3 Y	-41.34%
Net Income Growth5 Y	-19.42%
Pretax Margin	6.61%
Profit Margin	6.8%
Profit Per Employee	ARS 85.2M
Profitable Years	41
ROA	5.78
Roa5y	7.03
ROCE	11.18
ROE	5.01
Roe5y	17.68
ROIC	13.49
Roic5y	18.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	60.08%
Cagr15y	55.33%
Cagr1y	31.06%
Cagr20y	40.59%
Cagr3y	24.9%
Cagr5y	43.29%
Div CAGR10	4.41%
Div CAGR3	2.27%
Div CAGR5	-18.39%
EPS Growth	-59.88
EPS Growth Years	0
EPS Growth3 Y	-41.3
EPS Growth5 Y	-19.56
FCF Growth	-11.68%
FCF Growth Qo Q	-86.14%
FCF Growth3 Y	0.99%
FCF Growth5 Y	-12.27%
OCF Growth	-11.77%
OCF Growth Qo Q	-68.07%
OCF Growth10 Y	-1.34%
OCF Growth3 Y	-2.73%
OCF Growth5 Y	-10.66%
Revenue Growth	-0.21x
Revenue Growth Q	2.6x
Revenue Growth Qo Q	4.03x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-6.7x
Revenue Growth5 Y	2.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.31
Assets	ARS 296.5T
Cash	ARS 17.3T
Current Assets	ARS 62.6T
Current Liabilities	ARS 49.4T
Debt	ARS 93.6T
Debt EBITDA	ARS 2.41
Debt Equity	ARS 0.74
Debt FCF	ARS 5.78
Equity	ARS 126T
Interest Coverage	6.98
Liabilities	ARS 170.5T
Long Term Assets	ARS 233.9T
Long Term Liabilities	ARS 121.1T
Net Cash	ARS -76.3T
Net Cash By Market Cap	ARS -32.02
Net Debt EBITDA	ARS 2.04
Net Debt Equity	ARS 0.61
Net Debt FCF	ARS 4.71
Tangible Book Value	ARS -49.1T
Tangible Book Value Per Share	ARS -8,609
WACC	5.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.27
Inventory Turnover	1.49
Net Working Capital	ARS -418.7B
Quick ratio	0.85
Working Capital	ARS 12.8T
Working Capital Turnover	ARS 12,785

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.34%
Dividend Growth	1.16%
Dividend Growth Years	4%
Dividend per share	ARS 390
Dividend Years	27
Dividend Yield	3.52%
Ex Div Date	2026-07-24
Last Dividend	ARS 0.07
Payout Frequency	Quarterly
Payout Ratio	34.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	10,943.06%
1Y total return	31.04%
200-day SMA	9,932.2
3Y total return	94.86%
50-day SMA	10,407.1
50-day SMA vs 200-day SMA	50over200
5Y total return	503.93%
All Time High	11,650
All Time High Change	-4.72%
All Time High Date	2026-09-01
All Time Low	9.25
All Time Low Change	119,900%
All Time Low Date	2001-09-19
ATR	262.3
Beta	0.28
Ch YTD	17.03
High	11,110
High52	11,650
High52 Date	2026-09-01
High52ch	-4.72%
Low	10,930
Low52	8,050
Low52 Date	2025-10-27
Low52ch	37.89%
Ma50ch	6.66%
Price vs 200-day SMA	11.76%
RSI	54.69
RSI Monthly	65.72
RSI Weekly	66.14
Sharpe ratio	0.98x
Sharpe Ratio3y	0.83x
Sharpe Ratio5y	1.16x
Sortino ratio	1.67
Sortino Ratio3y	1.41
Sortino Ratio5y	1.93
Total Return	3.2%
Tr YTD	20.67
Tr15y	73,881.23%
Tr1m	3.93%
Tr1w	-1.33%
Tr3m	15.88%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,692,048,095%
Net Borrowing	2,689,625,761,200
Shares Insiders	0.03%
Shares Institutions	68.12%
Shares Qo Q	-0.56%
Shares Yo Y	0.34%
Short Ratio	3.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 14.8T
Adjusted OCF	18,359,686,800,000
Average Volume	29,041.45x
Bv Per Share	22,036.7
CAPEX	ARS -3.6T
Ch10y	8,438.5
Ch15y	52,506.6
Ch1m	3.93
Ch1w	-1.33
Ch1y	25.71
Ch20y	55,749.1
Ch3m	14.67
Ch3y	75.24
Ch5y	431.2
Ch6m	12.18
Change	0.82%
Change From Open	0.63
Close	11,010
Days Gap	0.18
Depreciation Amortization	9,891,711,390,600
Dollar Volume	88,611,300
Earnings Date	2026-10-27
EBIT	ARS 27.8T
EBITDA	ARS 37.4T
EPS	ARS 1,120
F Score	7
FCF	ARS 16.2T
FCF EV Yield	5.11x
Financing CF	-12,383,280,000,000
Fiscal Year End	December
Founded	1,849
Goodwill	108,037,335,342,600
Graham Number	6228.59175
Graham Upside	-43.53
Income Tax	ARS -241.8B
Investing CF	-8,380,827,000,000
Is Primary Listing	0
Last Earnings Date	2026-08-04
Last Report Date	2026-06-28
Last Split Date	2024-01-24
Last Split Type	Forward
Lynch Fair Value	ARS 1,478
Lynch Upside	-86.6
Ma150	10,016.4
Ma150ch	10.82%
Ma20	11,159
Ma20ch	-0.53%
Net CF	-972,972,000,000
Next Earnings Date	2026-10-27
Open	11,030
P FCF Ratio	14.72
P FCF Ratio SBC	16.11
P OCF Ratio	12.07
P OCF Ratio SBC	12.98
Payment Date	2026-09-01
Position In Range	94.44
Ppne	28,785,651,636,600
Price Date	2026-09-11
Price EBITDA	ARS 6.37
Relative Volume	0.27x
Revenue	93,900,643,200,000x
SBC By Revenue	1.49x
Share Based Comp	1,396,067,400,000
Tax By Revenue	-0.26x
Tr20y	90,948.96%
Tr6m	14.5%
Volume	7,983
Z Score	2.22

BCBA/PFE (BCBA/PFE)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/PFE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/PFE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BCBA/PFE

Frequently asked questions